Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001075753 | SCV001241383 | pathogenic | Retinal dystrophy | 2019-06-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002555918 | SCV003524058 | pathogenic | not provided | 2023-05-20 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 867170). For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This premature translational stop signal has been observed in individual(s) with Usher syndrome (PMID: 25211151). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Tyr1569*) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). |
Genome- |
RCV003455422 | SCV004182209 | pathogenic | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003455422 | SCV004200688 | pathogenic | Retinitis pigmentosa 39 | 2023-06-07 | criteria provided, single submitter | clinical testing |